Profile picture

Professor Gunnar Hilmar Gislason

Herlev and Gentofte Hospital, Copenhagen (Denmark)
Membership: FESC Member
Follow
Biography
Gunnar Gislason is a professor of cardiology at the University of Copenhagen and the Chief Medical Science Officer of the Danish Heart Foundation. His main research focus is the epidemiology, prevention and treatment of cardiovascular disease based on large-scale registries and randomized clinical trials. There is focus on drug-safety and drug-drug interactions, compliance, cardiac arrest as well as cardiovascular complications related to diabetes and metabolic disease. Dr. Gislason heads two research groups at the Danish Heart Foundation and the Copenhagen University Hospital Herlev- Gentofte, respectively, comprising more than 50 active researchers and an annual funding exceeding €2.5 million. Dr. Gislason is the author of more than 800 peer-reviewed scientific papers and his research groups publishes more than 120 scientific papers annually. Dr. Gislason has a major role in structuring and developing nationwide cardiovascular registries in Denmark.
Logo ESC

Contributor content

Public health and health economics
Session
Public health and health economics
31 August 2025
Risk factors and prevention: epidemiology (2)
Session
Risk factors and prevention: epidemiology (2)
30 August 2025
Exploring cardiovascular health: lifestyle, economics, and disparities
Session
Exploring cardiovascular health: lifestyle, economics, and disparities
1 September 2024
Innovations in public health and health economics (5)
Session
Innovations in public health and health economics (5)
28 August 2023
Innovations in public health and health economics (4)
Session
Innovations in public health and health economics (4)
28 August 2023
Innovations in public health and health economics (2)
Session
Innovations in public health and health economics (2)
26 August 2023
Innovations in public health and health economics (1)
Session
Innovations in public health and health economics (1)
25 August 2023
Coronary artery disease - Epidemiology, prognosis, outcome 1
Session
Coronary artery disease - Epidemiology, prognosis, outcome 1
26 August 2022
Adverse outcomes in atrial fibrillation: can they be prevented?
Session
Adverse outcomes in atrial fibrillation: can they be prevented?
31 August 2019

ESC 365 is supported by